Stock PYXS PYXIS ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Pyxis Oncology, Inc.

Equities

PYXS

US7473241013

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
4.19 USD +0.96% Intraday chart for Pyxis Oncology, Inc. -2.33% +132.78%
May. 14 Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M MT
May. 14 Pyxis Oncology, Inc. Appoints Stephen Worsley as its Senior Vice President CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pyxis Oncology : RBC Capital Markets Global Healthcare Conference
PU
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GL
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
AQ
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
GL
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
AQ
Pyxis Oncology : Stifel 2024 Virtual Targeted Oncology Forum
PU
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
GL
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
GL
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
GL
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
AQ
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
GL
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
GL
Pyxis Oncology Announces $50 Million Private Placement
GL
Pyxis Oncology Announces $50 Million Private Placement
AQ
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
GL
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update
GL
Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PYXS Stock
  4. News Pyxis Oncology, Inc.
  5. Press Releases
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW